Prognostic significance of PHH3, KI-67 and BCL-2 in prostate cancer
Date
2018
Authors
Phillips Adekoyejo Abiodun
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
INTRODUCTION: Prostate cancer is the second most common cancer in men and it is a
leading cause of cancer death. In 2012, 1.1 million new cases were diagnosed worldwide, and it
accounted for 15% of cancer cases diagnosed. Prostate cancer can be managed either by active
treatment or by watchful waiting/ active surveillance. Prognostic factors associated with prostate
cancer include Gleason score, age, extracapsular invasion, seminal vesicle invasion,
heterogeneity, prostate-specific antigen (PSA) assessment, and biomarkers. The Gleason score
has been described as a quintessential prognostic factor in prostate cancer. Like other prognostic
factors. the Gleason score has been modified to improve its reproducibility. The modified
Gleason grading system is still subjective in nature although not as much as it was before the
2014 International Society of Urological Pathology (!SUP) modification. Therefore, a need
exists to introduce a more objective and reliable method for predicting prognosis in prostate
cancer. The use of biomarkers could provide a more reliable approach for the prediction of
prognosis in prostate cancer. Some studies have linked the outcome of prostate cancer to genes
and proteins involved in cell proliferation and apoptosis. (Abbreviation abstract)
Description
A dissertation submitted in partial fulfillment of the requirements of a Master of Science in Medicine (Anatomical Pathology) at the University of the Witwatersrand